{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:34:53Z","timestamp":1770910493034,"version":"3.50.1"},"reference-count":27,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Hepatitis B virus (HBV) infection remains highly endemic in sub-Saharan Africa, where hepatitis delta virus (HDV) co-infection substantially worsens liver disease outcomes. Mauritania has long been suspected to be a high-burden setting for HBV-HDV co-infection, yet contemporary data describing its clinical and virological impact remain limited. Methods: We conducted a hospital-based cross-sectional study at the National Institute of Hepato-Virology (INHV) in Nouakchott, including 401 HBsAg-positive patients. Demographic, clinical, biological, and virological data were collected. HDV serology and RNA testing were performed when available. Liver disease severity, including cirrhosis and hepatocellular carcinoma (HCC), was assessed using clinical, biological, and imaging criteria. Results: HDV antibodies were detected in 31.9% of HBsAg-positive patients, confirming Mauritania as a hyper-endemic area for HDV. HDV co-infection was strongly associated with advanced liver disease, with HDV antibodies present in 86.4% of cirrhotic patients and 82.4% of those with HCC. Patients with HDV infection frequently exhibited suppressed HBV DNA levels, reflecting viral interference. A substantial proportion of patients presented with decompensated cirrhosis or HCC at diagnosis, and nearly 70% were treatment-na\u00efve. Overall, HDV co-infection emerged as the principal driver of severe liver disease in this cohort. Conclusions: HBV\/HDV co-infection is highly prevalent in Mauritania and is associated with a wide clinical spectrum ranging from asymptomatic infection to decompensated cirrhosis and hepatocellular carcinoma. HDV co-infection is the principal driver of severe liver disease, often occurring despite low or undetectable HBV DNA levels. Systematic HDV screening among all HBsAg-positive individuals is urgently needed to improve risk stratification, guide therapeutic decisions, and reduce liver-related morbidity and mortality.<\/jats:p>","DOI":"10.3390\/diseases14020069","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:06:16Z","timestamp":1770905176000},"page":"69","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9774-4795","authenticated-orcid":false,"given":"Mohamed","family":"Abdawa","sequence":"first","affiliation":[{"name":"Unit\u00e9 d\u2019\u00c9pid\u00e9miologie Mol\u00e9culaire et Diversit\u00e9 des Micro-Organismes (EMDM), Universit\u00e9 de Nouakchott, Nouakchott, Mauritania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hemeyine","sequence":"additional","affiliation":[{"name":"Institut National d\u2019H\u00e9pato-Virologie (INHV), Nouakchott, Mauritania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-5489","authenticated-orcid":false,"given":"Isabelle","family":"Chemin","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1350, 151 Cours Albert Thomas, 69003 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Lunel-Fabiani","sequence":"additional","affiliation":[{"name":"HIFIH UFR Sant\u00e9, Facult\u00e9 de M\u00e9decine, University of Angers, 4 Rue de Larrey, 49933 Angers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Vall","family":"Mohamed Abdellahi","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019\u00c9pid\u00e9miologie Mol\u00e9culaire et Diversit\u00e9 des Micro-Organismes (EMDM), Universit\u00e9 de Nouakchott, Nouakchott, Mauritania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"He, Q., Chang, X., Xu, R., Han, W., Wang, S., Gong, S., Huang, J., Liu, J., Zhang, R., and Yang, Y. (2025). Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: An analysis based on the global burden of disease study 2021. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1494388"},{"key":"ref_2","first-page":"147","article-title":"Epidemiological and Diagnostic Profile of Patients with Chronic Hepatitis B Virus from 2017 to 2021 in Parakou, Republic of Benin","volume":"14","author":"Attinsounon","year":"2024","journal-title":"Adv. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/liv.14744","article-title":"Prevalence of liver cirrhosis in individuals with hep-atitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis","volume":"41","author":"Surial","year":"2020","journal-title":"Liver Int."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mena, A.R., Ngom, N.F., Tine, J., Ndiaye, K., Fortes, L., Ndiaye, O., Fall, M., Gaye, A., Ka, D., and Seydi, M. (2022). Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal. Viruses, 14.","DOI":"10.3390\/v14081614"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.vaccine.2021.03.011","article-title":"From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study","volume":"39","author":"Pivert","year":"2021","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2147\/JHC.S372571","article-title":"Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population","volume":"9","author":"Bollerup","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dakurah, O.B., Tamandjou, C.R.T., Zunza, M., Preiser, W., and Maponga, T.G. (2021). Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: A systematic review. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08426-y"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jinf.2013.06.008","article-title":"Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: A cross sectional study","volume":"67","author":"Mansour","year":"2013","journal-title":"J. Infect."},{"key":"ref_9","unstructured":"Delphin, M. (2021). Polarization of Hepatic Macrophages by HBsAg: A Means to an End for Viral Maintenance. [Ph.D. Thesis, Universit\u00e9 de Lyon]. Available online: https:\/\/theses.hal.science\/tel-03623551."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bane, A., Sultan, A., Tibebu, Z., and Ahmed, R. (2023). Real world clinical experience of Chronic Hepatitis B Treatment in SSA. Res. Sq.","DOI":"10.21203\/rs.3.rs-2408194\/v1"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Nartey, Y.A., Okine, R., Seake-Kwawu, A., Ghartey, G., Asamoah, Y.K., Senya, K., Duah, A., Owusu-Ofori, A., Amugsi, J., and Suglo, D. (2022). A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016\u20132021. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-14618-3"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4236\/ojgas.2023.1312044","article-title":"Hepatitis B Virus in Cirrhosis and Primary Livers Cancers","volume":"13","author":"Oumarou","year":"2023","journal-title":"Open J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1383","DOI":"10.1016\/S2214-109X(23)00263-2","article-title":"Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: A prospective cohort study","volume":"11","author":"Ndow","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"H\u00f8nge, B.L., Jespersen, S., Medina, C., T\u00e9, D.d.S., da Silva, Z.J., Lewin, S., \u00d8stergaard, L., Erikstrup, C., Wejse, C., and Laursen, A.L. (2014). Hepatitis B and Delta Virus Are Prevalent but Often Subclinical Co-Infections among HIV Infected Patients in Guinea-Bissau, West Africa: A Cross-Sectional Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099971"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e101630","DOI":"10.5812\/hepatmon.101630","article-title":"Characteristics of Hepatitis B and D Co-infection: A Descriptive Study","volume":"21","author":"Hajiabdolbaghi","year":"2021","journal-title":"Hepat. Mon."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/jvh.13065","article-title":"Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia","volume":"26","author":"Mahale","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1016\/S2214-109X(16)30130-9","article-title":"Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study","volume":"4","author":"Lemoine","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e70026","DOI":"10.1111\/liv.70026","article-title":"Hepatitis Delta and Liver Disease Among People Living with Hepatitis B with or Without HIV Co-Infection in Senegal","volume":"45","author":"Wembulua","year":"2025","journal-title":"Liver Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1073\/pnas.88.19.8490","article-title":"The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus","volume":"88","author":"Chang","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies","volume":"73","author":"Alfaiate","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.46.3.420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B","volume":"46","author":"Fattovich","year":"2000","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ruggieri, A., Gagliardi, M.C., and Anticoli, S. (2018). Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses?. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02302"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3851\/IMP2728","article-title":"Treatment of chronic hepatitis D patients with pegylated interferon: A real-world experience","volume":"19","author":"Abbas","year":"2014","journal-title":"Antivir. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa2213429","article-title":"MYR301 Study Group APhase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D","volume":"389","author":"Wedemeyer","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.14218\/JCTH.2015.00018","article-title":"Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte","volume":"3","author":"Giersch","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"El Hachimi, H., El Alem, M.M.M., Haimoudane, E., Yebouk, C., Pedersen, J., Fall-Malick, F.-Z., Khiddi, F., Abdawe, M., Sadegh, S.A., and Fausther-Bovendo, H. (2023). The First Assessments of Pediatric HBV Immunization Coverage in Mauritania and Persistence of Antibody Titers Post Infant Immunizations. Vaccines, 11.","DOI":"10.3390\/vaccines11030588"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/2\/69\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:41:56Z","timestamp":1770907316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/2\/69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["diseases14020069"],"URL":"https:\/\/doi.org\/10.3390\/diseases14020069","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}